AG
RDY icon

AIA Group’s Dr. Reddy's Laboratories RDY Stock Holding History

AIA Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50,809
Closed -$764K – 412
2025
Q2 		$764K Buy
50,809
+6,952
+16% +$99.3K 0.02% 244
2025
Q1 		$578K Sell
43,857
-101,293
-70% -$1.4M 0.01% 252
2024
Q4 		$2.29M Buy
145,150
+11,185
+8% +$168K 0.06% 144
2024
Q3 		$2.13M Buy
133,965
+11,770
+10% +$189K 0.05% 152
2024
Q2 		$1.86M Buy
122,195
+60,150
+97% +$862K 0.05% 151
2024
Q1 		$910K Buy
62,045
+6,100
+11% +$89.1K 0.03% 215
2023
Q4 		$779K Hold
55,945
– – 0.03% 212
2023
Q3 		$748K Hold
55,945
– – 0.04% 186
2023
Q2 		$706K Buy
55,945
+41,220
+280% +$481K 0.03% 206
2023
Q1 		$168K Hold
14,725
– – 0.01% 339
2022
Q4 		$152K Buy
+14,725
New +$159K 0.01% 346

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AIA Group's RDY Position: Q3 2025 in Review

AIA Group sold out of Dr. Reddy's Laboratories (RDY) in Q3 2025, closing a stake of 50,809 shares — an estimated $764K sold.

AIA Group first reported a position in RDY in Q4 2022 and held it in 11 quarters. The position peaked at $2.29M in Q4 2024. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

  • AIA Group reported no remaining Dr. Reddy's Laboratories position as of Q3 2025 after selling out during the quarter.
  • AIA Group sold 50,809 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $764K.
  • AIA Group first reported a position in Dr. Reddy's Laboratories in Q4 2022 and held it in 11 quarters.
  • AIA Group's Dr. Reddy's Laboratories position peaked at $2.29M in Q4 2024.
  • 228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on AIA Group's 13F filing for Q3 2025, filed 18 Dec 2025.